Background: Warfarin is commonly initiated post-cardiac surgery to reduce the risk of intracardiac thrombus formation. Studies have found that sensitivity is increased after cardiac surgery and anticoagulation is subsequently difficult to manage. This study set out to identify clinical markers of increased warfarin sensitivity in patients after cardiac surgery, and build a model that can predict warfarin sensitivity, and improve safety in this setting. Methods: The study was an observational, retrospective cohort design. Clinical parameters including left ventricular ejection fraction (LVEF), cross-clamp time, age, serum albumin and C-reactive protein concentrations were collected from consenting patients who had undergone cardiac surgery and were prescribed postoperative warfarin. The warfarin dose index (WDI) was calculated for each patient from their international normalized ratio (INR) and warfarin dose, as a measure of sensitivity. Results: A total of 41 patients were recruited to the study. Logarithmically transformed WDI (log WDI) significantly correlated with LVEF, cardiopulmonary bypass (CPB) time, crossclamp time, baseline INR and co-administration of amiodarone (p < 0.05). When added to a linear regression model, LVEF and cross-clamp time produced a model that accounted for 41% of the variance in log WDI (R 2 = 0.41), p = 0.0002). Applying a log WDI cutoff value of −0.349 discriminated between patients who develop an INR > 4 and those who do not, with a sensitivity of 75% and a specificity of 70%. Conclusions: This single-centre study has highlighted two risk factors for increased warfarin sensitivity post-cardiac surgery. Further research is needed to confirm these findings in a wider, more diverse population, and to validate this model.

This Paper has been reviewed by IDA to assure that It meets high standards of thoroughness, objectivity, and appropriate analytical math. !ogy and that the results, I conclusions and recommendation are properly supported by the material presented.

No abstract

PLIcr1FnMnn0 won lot isodmito~d toa, A 144ix PauPr tNPOWe,~INu1Irrg th ~$lev~~Q~lUo3 a eI~gdaotwIir am mitainic t dam nrowa4W .omp.ng an lefti~arl n 0oWaiw *I intonation. senrd owlmmit repi~g Ihsttwrd.o..mw ovit Of &y other GAap f bs oham Nro4tornsklon. W41Ithw oggg.lnu for fmd~qInto~ h* rdor, to WssNrqtoA Headuarwms 64rvIsa 01iratit oar WoforrWnO~iftm 000m AndPOMA, 1116 44.Ifaro~jott Dit ihwaY. Sulle 1104, Mn~rQoh, VA 5U20.4L% azi to the Oflso IMohaeotomll md I~aft, PWfo4R,59uotlo Pfolm 0704-01111 WMrith O m Ow ______________3____ I. AGENCY USE ONLY (d"Vr W* ~ 2.n~I U REPORT OATS I. REPORT TYPE AND DATES COVERED

No abstract